Regeneron Pharmaceuticals
REGN
NASDAQ
IPO1991
about REGN
Regeneron Pharmaceuticals is a leading biopharmaceutical company focused on researching, developing, and producing innovative medicines and genetic-based treatments, including its widely used treatment for eye diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $723.00 | $736.15 | $717.26 | $75.97B | 798.43K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$14.09 | 15.87 | 20.50 | 27.35% | 38.89% | 0.49% |